<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The incidence of antepartum <z:e sem="disease" ids="C0035404" disease_type="Disease or Syndrome" abbrv="">Rh isoimmunization</z:e> has been limited by third-trimester Rh immune globulin (RhIg) administration </plain></SENT>
<SENT sid="1" pm="."><plain>Prophylactic failures are uncommon but can occur if sensitization takes place prior to the 28th week of gestation </plain></SENT>
<SENT sid="2" pm="."><plain>We report a case of midtrimester Rh sensitization in an anticardiolipin antibody-positive primipara coincident with the discovery of an <z:hpo ids='HP_0005984'>elevated maternal serum alpha-fetoprotein</z:hpo> value, <z:hpo ids='HP_0001562'>oligohydramnios</z:hpo> and fetal <z:hpo ids='HP_0001510'>growth retardation</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>This case suggests that fetal-maternal <z:mp ids='MP_0001914'>hemorrhage</z:mp> and subsequent sensitization may be facilitated by anticardiolipin antibody-induced placental damage </plain></SENT>
<SENT sid="4" pm="."><plain>Prophylactic midtrimester RhIg administration might avoid sensitization in similar cases </plain></SENT>
</text></document>